Skip to content

Evaluation of the effect of vegetable dietary supplement tablets and B vitamins for liver protection on mild fatty liver disease

Evaluation of the effect of vegetable dietary supplement tablets and B vitamins for liver protection on mild fatty liver disease

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400084011
Enrollment
Unknown
Registered
2024-05-09
Start date
2024-05-10
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-alcoholic fatty liver disease

Interventions

Intervention group:1.Take liver care combination (1) Plant dietary supplement tablets, 1 tablet each time, 3 times a day, with meals
(2) B vitamin tablets 1 tablet per day. The administration cycle of the above liver protection combination is 12 weeks. 2. Offer meal plans Registered dietitians first gave verbal dietary advice to pa
control group :Offer meal plans Registered dietitians first gave verbal dietary advice to patients at enrollment, asking them to adhere to the Mediterranean diet, that is, carbohydrates content of abo

Sponsors

Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) Age 18-60 years old; (2) Imaging diagnosis of mild FLD; (3) No liver protection drugs were taken in the first 3 months before enrollment; (4) Sign informed consent.

Exclusion criteria

Exclusion criteria: (1) Familial hyperlipidemia; (2) Suffering from cardiovascular and cerebrovascular diseases, any form of kidney and malignant tumors; (3) Have specific liver diseases that may cause FLD, such as viral hepatitis, hepatolenticular degeneration, autoimmune hepatitis, and drug-induced liver injury; (4) Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
controlled attenuation parameter;

Secondary

MeasureTime frame
Light FLD reversal rate;ALT;AST;GGT;ALP;TG;TC;LDL-C;HDL-C;Weight;BMI;Waistline;

Countries

China

Contacts

Public ContactYin Xiaoxv; Li Longti

Huazhong University of Science and Technology; Taihe Hospital

yxx@hust.edu.cn+86 138 7118 7781

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026